Stem Cell Therapy for Retinal Transplant in Mexico

Retinal degeneration is associated with the degeneration of retinal pigment epithelium which provides support for critical normal vision. Age-related macular disease and many other factors can cause retinal degeneration. Stem Cell Therapy for Retinal Transplant in Mexico aims at reversing blindness due to retinal degeneration.

A clinical study ^[1] da Cruz L, Fynes K1, Georgiadis O, Kerby J
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

“This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD….”
View in Article used an RPE patch on patients with Age-related macular degeneration (AMD). This work supported the feasibility and safety of hESC-RPE patch transplantation as a treatment for AMD.

Another phase 1 study used autologous bone marrow-derived mononuclear cells for patients with hereditary retinal dystrophy. It showed that the therapy did not have any adverse events and offers a promising treatment in this field.

References:

• Giostar: Stem Cell Treatment of Retinal Transplant
• Nature Biotechnology: Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.